Ajou University repository

  • Add filters:
  • Results/Page
  • Sort by
  • In order
  • Authors/record

Showing results 1 to 10 of 13803 (Search time: 0.0 seconds).

Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetesoa mark
  • 2019-01-29
  • Journal of Nanobiotechnology, Vol.17
  • BioMed Central Ltd.
Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitusoa mark
  • 2019-01-01
  • Cancer Management and Research, Vol.11, pp.7427-7438
  • Dove Medical Press Ltd
Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancyoa mark
  • 2019-04-01
  • International Journal of Cancer, Vol.144, pp.1530-1539
  • Wiley-Liss Inc.
Beneficial effects of dipeptidyl peptidase-4 inhibitors and sodium-glucose cotransporter 2 inhibitors on nonalcoholic fatty liver disease
  • 이나미
  • 2022-08
  • The Graduate School, Ajou University
Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patientsoa mark
  • 2023-12-01
  • Scientific Reports, Vol.13
  • Nature Research
리나글립틴 하이드록시신남산 공결정의 제조와 특성
  • 서명원
  • 2019-08
  • The Graduate School, Ajou University
Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patientsoa mark
  • 2018-01-01
  • Therapeutics and Clinical Risk Management, Vol.14, pp.1563-1571
  • Dove Medical Press Ltd.
1 2 3 4 1381

Discover